244460 — OliPass Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- KR₩7bn
- KR₩12bn
- KR₩756m
Annual balance sheet for OliPass, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 50,289 | 29,668 | 13,185 | 3,755 | 2,973 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 472 | 316 | 239 | 999 | 304 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 51,832 | 31,252 | 13,874 | 4,779 | 3,289 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 14,151 | 12,702 | 9,099 | 7,269 | 16,653 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 68,280 | 46,065 | 24,942 | 13,667 | 26,280 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17,424 | 10,996 | 12,041 | 7,758 | 11,001 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 24,836 | 15,261 | 14,480 | 11,347 | 14,422 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 43,444 | 30,804 | 10,462 | 2,320 | 11,857 |
Total Liabilities & Shareholders' Equity | 68,280 | 46,065 | 24,942 | 13,667 | 26,280 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |